Jan 8, 2024 07:10AM
Jan 8, 2024 07:03AM
Jan 8, 2024 07:00AM
Nov 13, 2023 08:05AM
Nov 13, 2023 08:05AM
Oct 31, 2023 04:03PM
Oct 31, 2023 04:03PM Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
Aug 17, 2023 07:03AM
Aug 17, 2023 07:00AM
May 31, 2023 07:00AM
May 4, 2023 07:30AM
Mar 21, 2023 05:34AM
Mar 21, 2023 03:51AM
Mar 21, 2023 03:30AM Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint
Mar 2, 2023 07:30AM
Jan 9, 2023 08:05AM
Jan 9, 2023 08:00AM
Jan 9, 2023 07:30AM
Dec 14, 2022 08:03AM
Dec 14, 2022 08:00AM
Nov 28, 2022 08:04AM Selecta Biosciences (SELB) Announces Appointment of Blaine Davis as Chief Financial Officer
Nov 28, 2022 08:00AM
Nov 3, 2022 08:00AM
Oct 11, 2022 08:00AM
Sep 29, 2022 08:00AM
Aug 4, 2022 07:30AM
Jun 13, 2022 07:32AM
Jun 13, 2022 07:30AM Selecta Biosciences Announces Partnership Advancements and Clinical Trial Updates
May 5, 2022 07:30AM
Mar 10, 2022 05:34PM
Mar 10, 2022 08:00AM
Nov 24, 2021 04:15PM
Nov 24, 2021 04:15PM
Nov 9, 2021 08:00AM
Nov 8, 2021 08:13AM Selecta Biosciences (SELB) Announces Top Line Data from Phase I SEL-399 AAV Empty Capsid Study, Highlighting Potential Benefits of ImmTOR in Gene Therapy
Nov 8, 2021 08:12AM
May 13, 2021 08:00AM
Mar 11, 2021 08:00AM
Dec 17, 2020 09:22AM
Dec 16, 2020 05:39PM
Nov 19, 2020 08:03AM
Nov 19, 2020 08:00AM AskBio and Selecta Biosciences Receive Orphan Drug Designation for MMA-101 to Treat Methylmalonic Acidemia
Nov 19, 2020 08:00AM
Nov 19, 2020 08:00AM
Nov 5, 2020 07:30AM
Oct 20, 2020 08:05AM
Oct 20, 2020 08:00AM
Oct 20, 2020 08:00AM
Sep 30, 2020 05:43PM Sobi and Selecta Biosciences announce topline data of SEL-212 from the phase 2 COMPARE study supporting the potential for important clinical improvement in patients with Chronic Refractory Gout
Sep 30, 2020 04:28PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All